BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33678142)

  • 1. Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.
    Alanazi SA; Harisa GI; Badran MM; Alanazi FK; Elzayat E; Alomrani AH; Al Meanazel OT; Al Meanazel AT
    Bioengineered; 2021 Dec; 12(1):914-926. PubMed ID: 33678142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition.
    Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK
    Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines.
    AlQahtani SA; Harisa GI; Badran MM; AlGhamdi KM; Kumar A; Salem-Bekhit MM; Ahmad SF; Alanazi FK
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):989-996. PubMed ID: 30873877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
    Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
    Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose Conjugated Starch Nanoparticles for Preferential Targeting of Liver Cancer.
    Jain AK; Sahu H; Mishra K; Thareja S
    Curr Drug Deliv; 2021; 18(3):369-380. PubMed ID: 32885751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
    Gupta Y; Jain A; Jain P; Jain SK
    J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma.
    Varshosaz J; Fard MM; Mirian M; Hassanzadeh F
    Anticancer Agents Med Chem; 2020; 20(3):346-358. PubMed ID: 31566137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
    Shah SM; Goel PN; Jain AS; Pathak PO; Padhye SG; Govindarajan S; Ghosh SS; Chaudhari PR; Gude RP; Gopal V; Nagarsenker MS
    Int J Pharm; 2014 Dec; 477(1-2):128-39. PubMed ID: 25311181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
    Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
    Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized PAMAM-based Nanoformulation for Targeted Delivery of 5-Fluorouracil in Hepatocellular Carcinoma.
    Chen S; Ouyang H; He D; Liu D; Wang X; Chen H; Pan W; Li Q; Xie W; Yu C
    Curr Pharm Des; 2022; 28(25):2113-2125. PubMed ID: 35524673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice.
    Zhang J; Li M; Liu Z; Wang L; Liu Y; Zhang N
    Int J Nanomedicine; 2014; 9():2741-51. PubMed ID: 24920908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
    Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
    J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
    Ali A; Madni A; Shah H; Jamshaid T; Jan N; Khan S; Khan MM; Mahmood MA
    PLoS One; 2023; 18(2):e0281004. PubMed ID: 36854019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
    Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK
    J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
    Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
    J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbitan Monolaurate-Containing Liposomes Enhance Skin Cancer Cell Cytotoxicity and in Association with Microneedling Increase the Skin Penetration of 5-Fluorouracil.
    Crisóstomo LCCF; Carvalho GSG; Leal LKAM; de Araújo TG; Nogueira KAB; da Silva DA; de Oliveira Silva Ribeiro F; Petrilli R; Eloy JO
    AAPS PharmSciTech; 2022 Aug; 23(6):212. PubMed ID: 35918472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer.
    Alomrani A; Badran M; Harisa GI; ALshehry M; Alhariri M; Alshamsan A; Alkholief M
    Saudi Pharm J; 2019 Jul; 27(5):603-611. PubMed ID: 31297013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil.
    Moghimipour E; Rezaei M; Ramezani Z; Kouchak M; Amini M; Angali KA; Dorkoosh FA; Handali S
    Eur J Pharm Sci; 2018 Mar; 114():166-174. PubMed ID: 29247686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.